ERBB2 and cholangiocarcinoma: For CC, these include molecular aberrations such as NTRK gene fusion, deficient mismatch repair proteins, BRAF mutation, FGFR2 fusion/rearrangements, IDH1 mutations, HER2 overexpression/amplification, RET gene fusion, and KRAS mutation [15].